Novo Nordisk
NVO
#25
Rank
โ‚น32.854 T
Marketcap
โ‚น7,274
Share price
-1.36%
Change (1 day)
-19.76%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.489 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น39.69 Billion. In 2023 the company made an earning of โ‚น1.335 Trillion, an increase over its 2022 earnings that were of โ‚น847.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น1.489 T11.49%
2023 โ‚น1.335 T57.64%
2022 โ‚น847.28 B5.35%
2021 โ‚น804.25 B12.47%
2020 โ‚น715.07 B13.07%
2019 โ‚น632.42 B-3.35%
2018 โ‚น654.34 B1.79%
2017 โ‚น642.81 B4.52%
2016 โ‚น615.00 B9.42%
2015 โ‚น562.07 B8.24%
2014 โ‚น519.29 B3.45%
2013 โ‚น501.98 B19.02%
2012 โ‚น421.77 B15.21%
2011 โ‚น366.11 B17.71%
2010 โ‚น311.01 B24.78%
2009 โ‚น249.24 B10.62%
2008 โ‚น225.30 B55.97%
2007 โ‚น144.45 B7.07%
2006 โ‚น134.92 B18.18%
2005 โ‚น114.16 B11.33%
2004 โ‚น102.55 B
2002 โ‚น62.65 B-14.39%
2001 โ‚น73.18 B-52.82%
2000 โ‚น155.09 B250%
1999 โ‚น44.31 B31.21%
1998 โ‚น33.77 B34.31%
1997 โ‚น25.14 B11.46%
1996 โ‚น22.55 B9.03%
1995 โ‚น20.68 B-3.15%
1994 โ‚น21.36 B-0.67%
1993 โ‚น21.50 B45.38%
1992 โ‚น14.79 B-13.81%
1991 โ‚น17.16 B37.12%
1990 โ‚น12.51 B-0.79%
1989 โ‚น12.61 B26.2%
1988 โ‚น9.99 B24.97%
1987 โ‚น7.99 B-0.9%
1986 โ‚น8.07 B-7.78%
1985 โ‚น8.75 B24.87%
1984 โ‚น7.01 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น601.00 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น878.65 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น595.56 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น641.24 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France